Intraventricular Hemorrhage in Kangaroo Care vs. Incubator Care

NCT07473882 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 314

Last updated 2026-03-16

No results posted yet for this study

Summary

This clinical study aims to find out whether kangaroo care (skin-to-skin contact between parents and their extremely premature newborns) can help protect the babies' brains by reducing the risk of bleeding in the brain during the first days of life. To do this, the extremely premature newborns will be randomly assigned to one of three groups: kangaroo care in a side-lying position, kangaroo care in a face-down position, or standard care in an incubator. Researchers will monitor the babies for signs of brain bleeding and other health measures to determine which approach is safest. The main hypothesis is that kangaroo care in the side-lying position may lower the risk of severe brain bleeding compared with the other positions or remaining in the incubator.

Conditions

  • Kangaroo Care
  • Premature Infant
  • IVH- Intraventricular Hemorrhage

Interventions

PROCEDURE

Lateral

lateral Kangaroo care position: The preterm infant will be placed unclothed against the parent's chest in a side-lying position, aligned along the midline.

PROCEDURE

Prone

prone kangaroo care position: The preterm infant will be positioned prone against the parent's chest, upright, with the head turned 90° to one side.

PROCEDURE

Incubator care

Kangaroo care will not be provided during the first three days of life, and the infant will remain in the incubator.

Sponsors & Collaborators

  • Hospital Universitario La Fe

    collaborator OTHER
  • Hospital Regional de Malaga

    collaborator OTHER
  • Germans Trias i Pujol Hospital

    collaborator OTHER
  • Hospital Universitario Vall d´Hebron

    collaborator UNKNOWN
  • Hospital de Cruces

    collaborator OTHER
  • Hospital Universitario 12 de Octubre

    lead OTHER

Principal Investigators

  • Laura Collados Gómez · Universidad Complutense de Madrid

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
1 Minute
Max Age
72 Hours
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2027-01-01
Primary Completion
2029-12-31
Completion
2029-12-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07473882 on ClinicalTrials.gov